Ombajo LA, Penner J, Nkuranga J, Omodi V, et al. Change in Blood Pressure, Weight, and Other Cardiovascular Disease Risk Factors After Switch From Protease Inhibitors to Dolutegravir: Post hoc Analysis of the 48-week Randomised Second-line Switch to Dolutegravir Trial. Clin Infect Dis 2025;80:889-892.
PMID: 39589132